Stock image of cells in acute myeloid leukemia (Image from National Cancer Institute).
Medicine by Design-funded researcher John Dick, senior scientist at the Princess Margaret Cancer Centre, University Health Network (UHN), and a professor in the Department of Molecular Genetics at the University of Toronto, and his team have developed a way to characterize the cancer cells found in acute myeloid leukemia (AML).
In individuals with AML, their cancer cells will have their own distinct caricature – meaning they will have their own proportions of different populations of cells within the disease.
This new research lays the groundwork for a potential method of customizing effective therapies for individual patients with AML.
Read the full story on the UHN website.
About Medicine by Design
Funded by a $114-million grant from the Canada First Research Excellence Fund, Medicine by Design brings together more than 150 principal investigators at the University of Toronto and its affiliated hospitals to advance regenerative medicine discoveries and accelerate them toward impact. It builds on decades of made-in-Canada excellence in regenerative medicine dating back to the discovery of stem cells in the early 1960s by Toronto researchers James Till and Dr. Ernest McCulloch.
